Article
FIBCD1 ameliorates weight loss in chemotherapy-induced murine mucositis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer - 1 May 2021
Andersen Maria C E, Johansen Malene W, Nissen Thomas, Nexoe Anders B, Madsen Gunvor I, Sorensen Grith L, Holmskov Uffe, Schlosser Anders, Moeller Jesper B, Husby Steffen, Rathe Mathias
Abstract excerpt
PURPOSE: Chemotherapy-induced gastrointestinal toxicity is a common adverse event during chemotherapeutic treatment. No uniformly applicable strategies exist to predict, prevent, or treat gastrointestinal toxicity. Thus, a goal of mucositis research is to identify targets for therapeutic interventions and individualized risk prediction. Fibrinogen C domain containing 1 (FIBCD1) is a transmembrane protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.